Spine Bone Stimulators Market Size & Share 2024 – 2032

Spine Bone Stimulators Market Size

Spine Bone Stimulators Market size was valued at around USD 661.7 million in 2023 and is anticipated to register a CAGR of over 5.7% between 2024 and 2032. The consistent increase in spinal deformities is expected to be the primary attribute for the rising demand for spine bone stimulators.

The rising prevalence of spinal deformities is correlated with a surge in demand for spine bone stimulators. Various factors such as congenital deformities, age-related degeneration, and diseases including tumors or infections, and idiopathic causes contribute to these deformities. Specifically, focusing on pediatric cases, the incidence of spinal deformity surgeries has witnessed a notable rise in recent decades.
 

For instance, according to a recent publication in PubMed, the worldwide estimated incidence of adolescent idiopathic scoliosis (AIS), a prevalent type of spinal deformity, ranges from 2% to 4%. It's important to recognize that the increasing incidence of spinal deformity surgeries doesn't necessarily indicate a higher prevalence of spinal deformities themselves. Instead, it reflects a shift toward earlier detection and intervention, potentially leading to improved long-term outcomes for affected individuals, and the increasing demand for spine bone stimulators.
 

Spine bone stimulators are medical devices designed to aid in the healing of spinal bone fractures, fusion procedures, or other spinal conditions by promoting bone growth and regeneration. These devices typically utilize electrical or electromagnetic fields, ultrasound waves, or other mechanisms to stimulate bone cells and accelerate the natural healing process.
 

Spine Bone Stimulators Market Trends

Research and utilization of advanced materials, coupled with the incorporation of electromagnetic fields, have led to significant advancements in bone growth stimulator devices. These advancements have resulted in higher efficacy and additional advantages, consequently fuelling the demand for spine bone stimulators in the market.
 

• Recent advancements in spine bone stimulators have seen researchers exploring innovative materials to enhance the bone healing process. Materials such as hydroxyapatite, ceramics, bioabsorbable substances, and metals like titanium and PEEK (polyetheretherketone) have shown to be promising in preclinical studies for their safety and potential to augment bone growth.
   
• For example, the use of bioabsorbable materials in spinal implants has been investigated. These materials aim to offer support during the healing phase and subsequently degrade over time, potentially reducing the necessity for additional surgeries. This research into advanced materials is anticipated to drive the market growth in the field of spine bone stimulators.
   
• Additionally, technological advancements have paved the way for newer models of spine bone stimulators, which leverage combined magnetic fields, including capacitive coupling and inductive coupling, to provide diverse stimulation mechanisms. For example, Orthofix's SpinalStim device utilizes a combination of magnetic fields to administer 360° of pulsed electromagnetic field (PEMF) treatment around the fusion site, ensuring uniform penetration across tissue, bone, and fixation.
   

Spine Bone Stimulators Market Analysis

Based on device type, the market is segmented into invasive spine bone stimulators and non-invasive spine bone stimulators. The non-invasive spine bone stimulators segment is anticipated to reach USD 834 million by 2032.
 

• The increasing preference among patients for non-invasive spine bone stimulators is driven by their safer, more comfortable, and convenient nature compared to invasive surgical procedures. By significantly reducing the risk of complications such as infections, bleeding, and tissue damage, non-invasive options provide patients with a more favorable treatment experience.
   
• Additionally, the cost-effectiveness of non-invasive spine bone stimulators, attributed to reduced healthcare resource utilization, shorter hospital stays, and fewer complications, is a significant driver contributing to their segment progress.

Learn more about the key segments shaping this market

Download Free PDF

The spine bone stimulators market by end-use is categorized into hospitals, specialty clinics, ambulatory surgical centers, and other end users. The hospitals segment dominates the market with a revenue of around USD 356 million in 2023.
 

• Hospitals typically have specialized spine care units with experienced orthopedic surgeons, neurosurgeons, and other healthcare professionals who are trained in the use of spine bone stimulators. They also have the necessary infrastructure and equipment to perform surgical procedures and administer spine treatments, anticipating them to be among the most prominent end-users. 
   
• Moreover, access to advanced medical technologies and equipment, including various types of spine bone stimulators, enables hospitals to provide the latest treatment options and techniques to patients with spinal disorders. This capability not only attracts more patients seeking cutting-edge treatments but also contributes to increased demand for spine bone stimulators in hospital settings.

North America spine bone stimulators market accounted for USD 368.4 million revenue in 2023 and is predicted to witness substantial market growth.
 

• There is a greater awareness among patients and healthcare providers in North America about the spinal deformity conditions and the available treatment options including spine bone stimulators which encourages the patients to seek for care.
   
• Furthermore, minimally invasive spine surgeries are becoming more common in the region due to their benefits such as preserving spinal anatomy and structures, leading to better long-term outcomes and reduced risk of adjacent segment disease. Spine bone stimulators are often used in conjunction with these procedures, leading to increased demand.
   

Spine Bone Stimulators Market Share

The spine bone stimulators industry is competitive in nature, with several large multinationals and small and mid-sized companies competing in the industry. The development and launch of novel advanced product based on different technologies is among a key market strategy. Some of the leading industry players including Medtronic plc, Inc., Orthofix Medical Inc., Zimmer Biomet Holdings, Inc., Elizur Corporation, Ossatec Benelux BV, and Theragen, Inc. among others have a notable presence in the market.
 

Spine Bone Stimulators Market Companies

Some of the eminent market participants operating in the spine bone stimulators industry include:

• Bioventus
• Elizur Corporation
• Enovis (DJO Global, Inc.)
• IGEA S.p.A.
• Medtronic plc
• Orthofix Medical Inc.
• Ossatec Benelux BV
• Synergy Orthopedics
• Theragen, Inc. (Neurotech NA Inc.)
• ZimVie Inc.
   

Spine Bone Stimulators Industry News

• In January 2023, Orthofix and SeaSpine have completed a merger of equals to create a leading global spine and orthopedics company. This merge may enable the Orthofix company to improve and expand its product offering, business in the spine segment and may increase its customer base.
   
• In July 2021, Bioventus launched OSTEOAMP SELECT Flowable, a flowable allograft bone graft substitute solution developed for a variety of patient procedures, including lumbar spine, cervical spine fusion and foot & ankle fusion. This launch improved the company’s product line in spine procedures and enhanced its positioning in the market.  
   

Spine bone stimulators market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2018 to 2032 for the following segments:

Click here to Buy Section of this Report

Market, By Device Type

• Invasive spine bone stimulators
• Non-invasive spine bone stimulators
  • Pulsed electromagnetic field devices
  • Capacitive coupling (CC) devices
  • Combined (electro) magnetic field (CMF) devices

Market, By End-use

• Hospitals
• Specialty clinics
• Ambulatory surgical centers
• Other end-users

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
• Middle East and Africa
  • Saudi Arabia
  • South Africa
  • UAE
  • Rest of Middle East and Africa